Breaking News, Collaborations & Alliances

Terumo and BioCentriq Form Strategic Collaboration

Aim to accelerate the adoption of automated manufacturing to bring novel cell and gene therapies to patients more quickly and cost effectively.

Author Image

By: Charlie Sternberg

Associate Editor

Terumo Blood and Cell Technologies and BioCentriq have formed a strategic collaboration designed to accelerate the adoption of automated manufacturing to bring novel cell and gene therapies (CGT) to patients more quickly and cost effectively.   Terumo is a medical technology company specializing in a portfolio of technology, software and services for blood component collection, therapeutic apheresis and cell and gene therapy technologies. BioCentriq is a contract development and manufacturing or...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters